ADHERENCE TO CONTINUOUS SCREENING FOR COLORECTAL NEOPLASIA

被引:62
|
作者
MYERS, RE
BALSHEM, AM
WOLF, TA
ROSS, EA
MILLNER, L
机构
[1] TEMPLE UNIV, SCH SOCIAL ADM, PHILADELPHIA, PA 19122 USA
[2] FOX CHASE CANC CTR, DIV POPULAT SCI, PHILADELPHIA, PA 19111 USA
关键词
ADHERENCE; COLON; CANCER; SCREENING; SERIAL; REPEAT;
D O I
10.1097/00005650-199306000-00004
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Continuous screening is defined as the periodic provision of an opportunity for diagnostic testing to a population of individuals who are asymptomatic and at increased risk for disease. If screening is offered periodically irrespective of response to an earlier screening invitation, this situation may be referred to as serial screening. When continuous screening is made available only to individuals who had tested previously, population member response is referred to as repeat screening. This study assessed adherence to serial- and repeat-colorectal cancer screening among older adult members of an independent practice association-type health maintenance organization (HMO) in two consecutive rounds of screening. In the first screening round, fecal occult blood tests (FOBTs) were sent to 1,565 subjects who were randomly assigned to receive usual care or behavioral interventions intended to encourage testing. Overall, 647 (41%) subjects completed and returned their tests. In the second screening round, FOBTs were mailed again to all subjects; however, the interventions were discontinued. Logistic regression analysis results shows that first-round testing was a significant independent predictor of serial adherence for subjects older than 65 years of age (odds ratio[OR] = 10.8) and those younger than 65 years of age (OR = 10.9); and a significant negative association between exposure to first-round intervention and serial adherence (OR = 0.5) was found among younger subjects. Among first-round adherers, age was significantly and positively related to repeat adherence (OR = 1.6). However, exposure to first-round intervention and having an abnormal FOBT result were significantly and negatively associated with repeat adherence (OR = 0.5 and OR = 0.4, respectively). The results of this study reported here indicate that previous screening is a strong predictor of serial adherence, and special efforts may be required to achieve high levels of serial and repeat adherence among younger adults. Additional research is needed to understand why persons with abnormal screening test results are unlikely to engage in repeat screening.
引用
收藏
页码:508 / 519
页数:12
相关论文
共 50 条
  • [1] SCREENING FOR COLORECTAL NEOPLASIA - PHYSICIANS ADHERENCE TO COMPLETE DIAGNOSTIC EVALUATION
    MYERS, RE
    BALSHEM, AM
    WOLF, TA
    ROSS, EA
    MILLNER, L
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1993, 83 (11) : 1620 - 1622
  • [2] Screening for colorectal neoplasia
    Kronborg, O
    [J]. ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (02): : 127 - 129
  • [3] SCREENING FOR COLORECTAL NEOPLASIA
    PYE, G
    HARDCASTLE, JD
    [J]. PRACTITIONER, 1987, 231 (1424) : 183 - &
  • [4] Screening for Colorectal Neoplasia
    Inadomi, John M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02): : 149 - 156
  • [5] DIAGNOSIS AND SCREENING OF COLORECTAL NEOPLASIA
    MCGILL, DB
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 1992, 8 (01) : 25 - 30
  • [6] COLORECTAL NEOPLASIA - DIAGNOSIS AND SCREENING
    AHLQUIST, DA
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 1990, 6 (01) : 33 - 37
  • [7] DIAGNOSIS AND SCREENING OF COLORECTAL NEOPLASIA
    LARSON, MV
    MCGILL, DB
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 1994, 10 (01) : 27 - 33
  • [8] Screening for Colorectal Neoplasia REPLY
    Inadomi, John M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (16): : 1599 - 1600
  • [9] LIMITED VALUE OF LEUKOCYTE ADHERENCE INHIBITION IN SCREENING FOR COLORECTAL NEOPLASIA IN HIGH-RISK GROUPS
    SHANI, A
    ROZEN, P
    FINK, A
    BASS, D
    FRASER, D
    BENTWICH, Z
    [J]. CANCER DETECTION AND PREVENTION, 1989, 13 (5-6): : 311 - 316
  • [10] Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test
    Hassan, C.
    Rossi, P. Giorgi
    Camilloni, L.
    Rex, D. K.
    Jimenez-Cendales, B.
    Ferroni, E.
    Borgia, P.
    Zullo, A.
    Guasticchi, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (10) : 929 - 940